EcoSynthetix AI Stock Analysis
EcoSynthetix (0Y8) AI Stock Analysis
EcoSynthetix
(Stuttgart:0Y8)
No summary available
EcoSynthetix (0Y8) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 103.46M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -64.7
- Beta (1Y)
- 0.32
- Revenue Growth
- -16.13%
- EPS Growth
- -28.91%
- Country
- Germany
- Employees
- 28
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
EcoSynthetix Business Overview & Revenue Model
Company Description
EcoSynthetix Inc., established in Burlington, Canada, in 1996, operates as a renewable chemistry company. It focuses on developing and commercializing bio-based technologies that serve as sustainable alternatives to conventional synthetic, petrochemi...
EcoSynthetix Earnings Call Summary
The call highlighted meaningful product validation, expanding distribution, new trials and a strong cash position, but these positives were outweighed by a 38% sales decline, sharply lower volumes from two concentrated strategic customers, weakened pulp-market economics, an uncertain recovery timeline and management's acknowledgement that current results are unacceptable.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said it does not expect an immediate change in market conditions, while the international retailer plans its own trials of the next-generation DuraBind product in the coming quarter and Dow is expected to launch another MaizeCare product next spring during personal care show season; SurfLock opportunities were described as a few hundred thousand dollars for a new tissue mill, a few million dollars for a packaging line, and in the tens of millions of dollars for a large pulp mill, with 2 additional pulp producers progressing toward mill trials over the next few months. A tissue mill represents an opportunity of about $200,000 to $300,000 annually, and some North American tissue, packaging and pulp programs could be real in 2027; the DuraBind change agenda represents approximately $60 million, and the Board committed up to CAD 500,000 to share purchases through the NCIB in Q4.
EcoSynthetix Peers Comparison
Overall Rating
TSE:BOS51Neutral
TSE:NANO45Neutral
TSE:CNO43Neutral
TSE:GMG42Neutral
TSE:SURE39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 51Neutral | CAD 177.70M | -93.88 | -1.34% | 2.15% | 4.72% | 59.65% | |
| 45Neutral | CAD 82.65M | -4.98 | -81.75% | ― | ― | -42.93% | |
| 43Neutral | CAD 19.64M | -6.98 | -89.62% | ― | -29.28% | -95.12% | |
| 42Neutral | CAD 247.48M | -8.33 | -969.63% | ― | 224.03% | -204.33% | |
| 39Underperform | CAD 4.20M | -4.20 | -24.00% | ― | ― | -904.55% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:0Y8 | EcoSynthetix Inc. | 1.05 | -1.51 | -58.98% | |
| TSE:BOS | Airboss of America | 6.52 | 2.24 | 52.19% | |
| TSE:CNO | California Nanotechnologies | 0.41 | 0.06 | 15.71% | |
| TSE:NANO | Nano One Materials | 0.69 | -0.93 | -57.41% | |
| TSE:GMG | Graphene Manufacturing Group Ltd | 1.83 | 0.77 | 72.64% | |
| TSE:SURE | SureNano Science Ltd | 0.10 | -0.05 | -33.33% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
